One Bio Corp Stock Performance
| ONBI Stock | USD 0.0005 0.00 0.00% |
ONE Bio holds a performance score of 9 on a scale of zero to a hundred. The company holds a Beta of 4.5, which implies a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, ONE Bio will likely underperform. Use ONE Bio coefficient of variation, treynor ratio, as well as the relationship between the Treynor Ratio and rate of daily change , to analyze future returns on ONE Bio.
Risk-Adjusted Performance
Fair
Weak | Strong |
Compared to the overall equity markets, risk-adjusted returns on investments in ONE Bio Corp are ranked lower than 9 (%) of all global equities and portfolios over the last 90 days. Despite fairly unfluctuating fundamental drivers, ONE Bio demonstrated solid returns over the last few months and may actually be approaching a breakup point. ...more
ONE |
ONE Bio Relative Risk vs. Return Landscape
If you would invest 0.02 in ONE Bio Corp on September 26, 2025 and sell it today you would earn a total of 0.03 from holding ONE Bio Corp or generate 150.0% return on investment over 90 days. ONE Bio Corp is currently generating 2.3438% in daily expected returns and assumes 18.75% risk (volatility on return distribution) over the 90 days horizon. In different words, most equities are less risky than ONE, and most traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon. Expected Return |
| Risk |
ONE Bio Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for ONE Bio's investment risk. Standard deviation is the most common way to measure market volatility of pink sheets, such as ONE Bio Corp, and traders can use it to determine the average amount a ONE Bio's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.125
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ONBI | |||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns |
Based on monthly moving average ONE Bio is performing at about 9% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of ONE Bio by adding it to a well-diversified portfolio.
ONE Bio Fundamentals Growth
ONE Pink Sheet prices reflect investors' perceptions of the future prospects and financial health of ONE Bio, and ONE Bio fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on ONE Pink Sheet performance.
| Return On Equity | 0.2 | |||
| Return On Asset | 0.13 | |||
| Profit Margin | 0.17 % | |||
| Operating Margin | 0.28 % | |||
| Current Valuation | 4.4 M | |||
| Shares Outstanding | 20.01 M | |||
| Price To Book | 0.01 X | |||
| Price To Sales | 0.01 X | |||
| Revenue | 52.3 M | |||
| EBITDA | 16.07 M | |||
| Cash And Equivalents | 14.46 M | |||
| Cash Per Share | 1.71 X | |||
| Debt To Equity | 0.54 % | |||
| Book Value Per Share | 5.75 X | |||
| Cash Flow From Operations | 8.76 M | |||
| Earnings Per Share | 0.10 X | |||
| Total Asset | 70.09 M | |||
| Retained Earnings | 23.22 M | |||
| Current Asset | 49.78 M | |||
| Current Liabilities | 31.63 M | |||
About ONE Bio Performance
By evaluating ONE Bio's fundamental ratios, stakeholders can gain valuable insights into ONE Bio's financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if ONE Bio has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if ONE Bio has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements. Please also refer to our technical analysis and fundamental analysis pages.
ONE Bio Corp., an agritech company, together with its subsidiaries, utilizes green process manufacturing to produce raw chemicals and herbal extracts, natural supplements, and organic products. ONE Bio Corp. was incorporated in 2000 and is headquartered in Aventura, Florida. One Bio operates under Biotechnology classification in the United States and is traded on OTC Exchange. It employs 358 people.Things to note about ONE Bio Corp performance evaluation
Checking the ongoing alerts about ONE Bio for important developments is a great way to find new opportunities for your next move. Pink Sheet alerts and notifications screener for ONE Bio Corp help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| ONE Bio Corp is way too risky over 90 days horizon | |
| ONE Bio Corp has some characteristics of a very speculative penny stock | |
| ONE Bio Corp appears to be risky and price may revert if volatility continues |
- Analyzing ONE Bio's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether ONE Bio's stock is overvalued or undervalued compared to its peers.
- Examining ONE Bio's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating ONE Bio's management team can have a significant impact on its success or failure. Reviewing the track record and experience of ONE Bio's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of ONE Bio's pink sheet. These opinions can provide insight into ONE Bio's potential for growth and whether the stock is currently undervalued or overvalued.
Complementary Tools for ONE Pink Sheet analysis
When running ONE Bio's price analysis, check to measure ONE Bio's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy ONE Bio is operating at the current time. Most of ONE Bio's value examination focuses on studying past and present price action to predict the probability of ONE Bio's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move ONE Bio's price. Additionally, you may evaluate how the addition of ONE Bio to your portfolios can decrease your overall portfolio volatility.
| Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
| Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |
| My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
| Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
| FinTech Suite Use AI to screen and filter profitable investment opportunities | |
| Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon |